Dermatologic Disease-Directed Targeted Therapy (D3T2): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions—Precision Dermatology
Crossref DOI link: https://doi.org/10.1007/s13555-022-00801-2
Published Online: 2022-09-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cohen, Philip R.
Kurzrock, Razelle
Text and Data Mining valid from 2022-09-19
Version of Record valid from 2022-09-19
Article History
Received: 4 August 2022
Accepted: 23 August 2022
First Online: 19 September 2022